Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $57.3003 (-0.61%) ($57.1613 - $57.8192) on Tue. Feb. 28, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.11% (three month average) | RSI | 66 | Latest Price | $57.3003(-0.61%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV advances 1.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(49%) IVE(47%) IWD(47%) SPLV(47%) | Factors Impacting ABBV price | ABBV will decline at least -0.555% in a week (0% probabilities). VIXM(-17%) TLT(-13%) UUP(-10%) IGOV(-3%) IPO(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.555% (StdDev 1.11%) | Hourly BBV | 0 () | Intraday Trend | -0.4% | | | |
|
5 Day Moving Average | $57.35(-0.09%) | 10 Day Moving Average | $57.19(0.19%) | 20 Day Moving Average | $56.74(0.99%) | To recent high | -2.7% | To recent low | 5.6% | Market Cap | $101.094b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |